Why the study?
Does routine preoperative coagulation testing predict postoperative bleeding in neurosurgical patients?
Does routine preoperative coagulation testing predict postoperative bleeding in neurosurgical patients?
Routine screening of all preoperative neurosurgical patients with coagulation studies is unnecessary as prolonged aPTT is predictable on history in most patients.
Answers are grounded in this paper and cite their sources.
May not warrant routine coagulation testing in neurosurgery; leaves open whether history-guided strategies reduce unnecessary tests.
Unselected preoperative coagulation testing is known to have low positive yield. However, no study has specifically evaluated neurosurgical patients. A retrospective study of 1211 patients having neurosurgery over a one-year period was therefore conducted. Preoperative test results (activated partial thromboplastin time [aPTT], prothrombin time [PT] and platelet count) and historical factors indicating a potential bleeding tendency were recorded. Abnormality was defined as a test result outside the normal range for our laboratory. Seventeen per cent of all test results were abnormal. However, if abnormality was redefined as a test result indicating potential bleeding tendency (low platelet count, prolonged aPTT and/or PT), only 7.2% of results were abnormal. Many patients had factors on history indicating a potential bleeding tendency, but only a prolonged aPTT, cranial surgery and the use of anti-hypertensive and anaesthetic drugs preoperatively predicted postoperative bleeding. Prolonged aPTT was predictable on history in most patients. We conclude that routine screening of all preoperative neurosurgical patients in our hospital is unnecessary.
No takes yet. Share an insight, caveat, or question.
Schramm et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: